On Wednesday, Viacom, Inc. (NASDAQ:VIAB)’s shares declined -2.98% to $61.17.
Janet Jackson stands as one of the best-selling artists of all time with a string of hits that have left an indelible impression on pop culture. She is the first African-American female artist to have hit singles in each of the last four decades. Her music has won her 6 GRAMMY® Awards, 2 Emmy Awards, a Golden Globe Award, a nomination for an Academy Award together with dozens of American Music Awards, MTV Video Music Awards, BET Awards and Billboard Music Awards. BET Networks, a partner of Viacom, Inc. (VIAB), Janet Jackson, one of the world’s most influential entertainers, will be receiving the inaugural ULTIMATE ICON: Music Dance Visual award at the 15th annual “BET Awards” 2015 on Sunday, June 28, 2015, it was declared by Stephen G. Hill, BET’s President of Programming.
Ciara, Jason Derulo and Tinashe are slated to perform a special dance tribute to the iconic entertainer, which is set to comprise her just released single, “No Sleeep.” The entertainer sent her fans into social media frenzy when she recently declared her forthcoming first studio album in seven years and the first leg of her highly anticipated UNBREAKABLE WORLD TOUR, a 37-date tour starting August 31st in Vancouver, BC.
Viacom Inc. operates as an entertainment content company in the United States and internationally. The company creates television programs, motion pictures, short-form video, applications, games, consumer products, social media, and other entertainment content.
Pioneer Natural Resources (NYSE:PXD)’s shares dropped -0.85% to $134.88.
Pioneer Natural Resources Company (PXD) declared that Mona K. Sutphen and Michael D. Wortley have been designated to its Board of Directors, effective right away. Ms. Sutphen and Mr. Wortley will serve as independent directors under the board’s appointment for initial terms that expire at Pioneer’s annual meeting of stockholders in 2016.
Ms. Sutphen is a Partner at Macro Advisory Partners LLP, and formerly spent three years at UBS AG as Managing Director, covering geopolitical risk and macro-policy trends. From 2009 through 2011, she served as White House Deputy Chief of Staff for Policy for President Obama, working on a range of domestic and international policy and regulatory matters. Prior to that position, she was Managing Director at Stonebridge International, and from 1991 through 2000 was a career diplomat, serving on the staff of the National Security Council, the U.S. Mission to the UN and postings in Asia and Europe.
Pioneer Natural Resources Company engages in the exploration and production of oil and gas in the United States. The company produces and sells oil, natural gas liquids (NGLs), and gas. It has operations primarily in the Permian Basin in West Texas, the Eagle Ford Shale play in South Texas, the Raton field in southeastern Colorado, and the West Panhandle field in the Texas Panhandle. As of December 31, 2014, the company had proved undeveloped reserves and proved developed reserves of about 89 MMBbls of oil, 42 MMBbls of NGLs, and 317 billion cubic feet of gas; and owned interests in 6 gas processing plants and 8 treating facilities.
At the end of Wednesday’s trade, GlaxoSmithKline plc (ADR) (NYSE:GSK)‘s shares dipped -1.12% to $41.34.
GlaxoSmithKline (GSK) declared that the U.S. Centers for Disease Control (CDC) Advisory Committee on Immunization Practices (ACIP) voted for a Category B recommendation for meningococcal group B vaccination, counting BEXSERO® (Meningococcal Group B Vaccine), in individuals aged 16 to 23 (with a preferred age of 16-18). This recommendation means that the decision to vaccinate against meningococcal group B will be made by qualified healthcare professionals, based on individual patient risk assessment. BEXSERO®
GlaxoSmithKline plc creates, discovers, develops, manufactures, and markets pharmaceutical products, counting vaccines, over-the-counter medicines, and health-related consumer products worldwide. The company offers pharmaceutical products in the therapeutic areas, counting respiratory, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterials, and emesis, dermatology, rare diseases, immuno-inflammation, vaccines, and HIV. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health areas.
Cardinal Health Inc (NYSE:CAH), ended its Wednesday’s trading session with -1.88% loss, and closed at $83.40.
Cardinal Health Inc (CAH) declared the completion of the acquisition of The Harvard Drug Group (THDG). A distributor of generic pharmaceuticals, over-the-counter medications and related products to retail, institutional and alternate care customers, THDG was owned by Court Square Capital Partners. The $1.115 billion acquisition was an all-cash transaction using existing cash and new debt.
Headquartered in Livonia, Mich., The Harvard Drug Group had revenues of about $450 million in 2014. There are 450 employees and two distribution facilities comprised of in the transaction.
In addition to enhancing the company’s generic pharmaceutical distribution business, the acquisition expands Cardinal Health’s existing telesales programs and capabilities; broadens the company’s portfolio of over-the counter pharmaceutical products; and brings specialized packaging offerings to meet the needs of hospital systems and other institutions.
Cardinal Health, Inc., a healthcare services company, provides pharmaceutical and medical products and services in the United States and internationally. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, over-the-counter healthcare, specialty pharmaceutical, and consumer products to retailers, including chain and independent drug stores and pharmacy departments of supermarkets and mass merchandisers; hospitals; and other healthcare providers.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
